Epidemiological impact of targeted interventions for people with diabetes mellitus on tuberculosis transmission in India: Modelling based predictions

被引:19
作者
Awad, Susanne F. [1 ,2 ]
Critchley, Julia A. [2 ]
Abu-Raddad, Laith J. [1 ,3 ,4 ]
机构
[1] Cornell Univ, Qatar Fdn Educ City, Weill Cornell Med Qatar, Infect Dis Epidemiol Grp, Doha, Qatar
[2] St Georges Univ London, Populat Hlth Res Inst, London, England
[3] Cornell Univ, Dept Healthcare Policy & Res, Weill Cornell Med, New York, NY USA
[4] Hamad bin Khalifa Univ, Coll Hlth & Life Sci, Doha, Qatar
关键词
Tuberculosis; Diabetes mellitus; Interventions; Vaccine; Latent tuberculosis infection; Diabetes mellitus management; Mathematical modelling; ADULTS;
D O I
10.1016/j.epidem.2019.100381
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: Diabetes mellitus (DM) is a leading driver of tuberculosis (TB) disease in TB-DM burdened countries. We aimed to assess the impact on TB disease of several intervention strategies targeting people with DM in India. Methods: A previously validated TB-DM mathematical model was extended to include interventions targeting DM individuals. The model stratified the population by age, DM status, TB infection status and stage, TB disease form, treatment, recovery, and intervention status. Results: By 2050, different TB vaccination strategies (coverage of 50 % and vaccine efficacies ranging between 50 %-60 %) reduced TB incidence and mortality rates by 4.5 %-20.8 % and 4.1 %-22.1 %, respectively, and averted 3.1 %-12.8 % of TB disease cases in the total population. Number of vaccinations needed to avert one TB case (effectiveness) was 14-105. Varying the coverage levels of latent TB treatment (coverage of 50 %-80 % and drug effectiveness of 90 %) reduced TB incidence and mortality rates by 7.1 %-11.3 % and 8.2 %-13.0 %, respectively, averting 4.2 %-6.7 % of TB cases, with effectiveness of 38-40. Different scenarios for dual and concurrent treatment of those with TB and DM, reduced TB incidence and mortality rates by 0.1 %-0.4 % and 1.3 %-4.8 %, respectively, averting 0.1 %-0.2 % of TB cases, with effectiveness of 28-107. Different scenarios for managing and controlling DM (regardless of TB status) reduced TB incidence and mortality rates by 4.5 %-16.5 % and 6.5 %-22.2 %, respectively, averting 2.9 %-10.8 % of TB cases, with effectiveness of 6-24. Conclusion: Gains can be attained by targeting DM individuals with interventions to reduce TB burden. Most strategies were effective with < 50 intervention doses needed to avert one TB disease case, informing key updates of current treatment guidelines.
引用
收藏
页数:10
相关论文
共 36 条
[1]   Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics [J].
Abu-Raddad, Laith J. ;
Sabatelli, Lorenzo ;
Achterberg, Jerusha T. ;
Sugimoto, Jonathan D. ;
Longini, Ira M., Jr. ;
Dye, Christopher ;
Halloran, M. Elizabeth .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (33) :13980-13985
[2]   Association between diabetes mellitus and active tuberculosis: A systematic review and meta-analysis [J].
Al-Rifai, Rami H. ;
Pearson, Fiona ;
Critchley, Julia A. ;
Abu-Raddad, Laith J. .
PLOS ONE, 2017, 12 (11)
[3]  
Algazaq JN, 2017, CASE REP INFECT DIS, V2017, DOI 10.1155/2017/2941527
[4]  
Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc11-S062, 10.2337/dc11-S011, 10.2337/dc12-s011, 10.2337/dc13-S011, 10.2337/dc10-S011, 10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc14-S081, 10.2337/dc12-s064]
[5]   Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR-INDIAB population-based cross-sectional study [J].
Anjana, Ranjit Mohan ;
Deepa, Mohan ;
Pradeepa, Rajendra ;
Mahanta, Jagadish ;
Narain, Kanwar ;
Das, Hiranya Kumar ;
Adhikari, Prabha ;
Rao, Paturi Vishnupriya ;
Saboo, Banshi ;
Kumar, Ajay ;
Bhansali, Anil ;
John, Mary ;
Luaia, Rosang ;
Reang, Taranga ;
Ningombam, Somorjit ;
Jampa, Lobsang ;
Budnah, Richard O. ;
Elangovan, Nirmal ;
Subashini, Radhakrishnan ;
Venkatesan, Ulagamathesan ;
Unnikrishnan, Ranjit ;
Das, Ashok Kumar ;
Madhu, Sri Venkata ;
Ali, Mohammed K. ;
Pandey, Arvind ;
Dhaliwal, Rupinder Singh ;
Kaur, Tanvir ;
Swaminathan, Soumya ;
Mohan, Viswanathan .
LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (08) :585-596
[6]  
[Anonymous], FORECASTING IMPACT D
[7]  
[Anonymous], DEF NUMB NEED TREAT
[8]  
[Anonymous], ENDTB STRAT GLOB STR
[9]  
[Anonymous], LANG TECHN COMP
[10]  
[Anonymous], WHO GLOB HLTH OBS DA